Swiss National Bank lifted its stake in Varian Medical Systems, Inc. (NYSE:VAR) by 0.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 510,948 shares of the medical equipment provider’s stock after buying an additional 600 shares during the period. Swiss National Bank owned approximately 556,588.24% of Varian Medical Systems worth $51,125,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Oregon Public Employees Retirement Fund boosted its position in shares of Varian Medical Systems by 1.5% in the third quarter. Oregon Public Employees Retirement Fund now owns 35,815 shares of the medical equipment provider’s stock worth $3,584,000 after buying an additional 529 shares during the period. Pettee Investors Inc. purchased a new stake in shares of Varian Medical Systems in the third quarter worth about $686,000. Wesbanco Bank Inc. boosted its position in shares of Varian Medical Systems by 16.1% in the third quarter. Wesbanco Bank Inc. now owns 6,845 shares of the medical equipment provider’s stock worth $685,000 after buying an additional 950 shares during the period. American Century Companies Inc. boosted its position in shares of Varian Medical Systems by 582.5% in the third quarter. American Century Companies Inc. now owns 137,303 shares of the medical equipment provider’s stock worth $13,739,000 after buying an additional 117,184 shares during the period. Finally, State of Tennessee Treasury Department boosted its position in shares of Varian Medical Systems by 126.6% in the third quarter. State of Tennessee Treasury Department now owns 75,843 shares of the medical equipment provider’s stock worth $7,589,000 after buying an additional 42,370 shares during the period. 99.15% of the stock is owned by institutional investors.

Varian Medical Systems, Inc. (NYSE VAR) opened at $108.24 on Tuesday. The company has a market capitalization of $9,873.19, a PE ratio of 28.53, a P/E/G ratio of 3.16 and a beta of 0.65. Varian Medical Systems, Inc. has a 1-year low of $76.94 and a 1-year high of $108.78. The company has a quick ratio of 1.13, a current ratio of 1.41 and a debt-to-equity ratio of 0.18.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The firm had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. During the same quarter in the previous year, the company earned $1.03 EPS. The company’s quarterly revenue was down 1.1% compared to the same quarter last year. equities analysts forecast that Varian Medical Systems, Inc. will post 4.26 EPS for the current fiscal year.

VAR has been the subject of several analyst reports. Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Citigroup Inc. upped their target price on Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a research report on Monday, October 30th. BidaskClub downgraded Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $100.00 target price on shares of Varian Medical Systems in a research report on Friday, September 1st. Finally, BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a report on Sunday, October 29th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $97.83.

TRADEMARK VIOLATION NOTICE: This article was posted by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/swiss-national-bank-has-51-13-million-stake-in-varian-medical-systems-inc-var/1702210.html.

In other Varian Medical Systems news, insider Dow R. Wilson sold 15,059 shares of the company’s stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $105.41, for a total transaction of $1,587,369.19. Following the sale, the insider now owns 81,835 shares in the company, valued at $8,626,227.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Kolleen T. Kennedy sold 931 shares of the company’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $105.00, for a total value of $97,755.00. Following the sale, the executive vice president now owns 27,531 shares in the company, valued at approximately $2,890,755. The disclosure for this sale can be found here. Insiders have sold 40,740 shares of company stock worth $4,230,890 in the last 90 days. 0.91% of the stock is currently owned by insiders.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.